ARCHIVES

GSK’s Votrient Approved For Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

OMB Ploy Would Delay Funding 1,500 NIH Grants From FY 1985 To 1986; Other Cuts Are Considered

January 18, 1985

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

CVS To Stop Tobacco Sales at Pharmacies

February 7, 2014

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996